Quantcast

Latest Inhaler Stories

2010-08-04 16:19:27

For many people afflicted by asthma, treatment can be a frustrating and time-consuming experience. After their initial diagnosis, asthmatics find themselves caught in a trial and error process that can last for months, as doctors gradually escalate their medications to treat their condition effectively with minimal side effects. And until the right medicine and dosage are found, patients continue to suffer attacks that strike without warning and can leave them struggling for breath for hours...

2010-07-28 09:45:00

HORSHAM, Pa., July 28 /PRNewswire/ -- Teva Respiratory today announced positive results from a Phase III trial evaluating the efficacy and safety of beclomethasone dipropionate (BDP) hydrofluoroalkane (HFA) Nasal Aerosol in the treatment of seasonal allergic rhinitis (SAR). The study met all efficacy endpoints, demonstrating a statistically significant benefit as compared to placebo. Furthermore, the safety profile of BDP HFA Nasal Aerosol was similar to placebo. "The outcomes of the...

2010-07-16 16:20:00

SILVER SPRING, Md., July 16 /PRNewswire-USNewswire/ -- The public should be on the lookout for stolen inhalers after some were found in a number of pharmacies. The Food and Drug Administration (FDA) says the safety and effectiveness of the stolen Advair Diskus inhalers cannot be assured, so consumers should not use them. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO) The inhalers--used in the treatment of asthma and...

2010-07-16 13:22:00

SILVER SPRING, Md., July 16 /PRNewswire-USNewswire/ -- The FDA is warning the public that certain Advair Diskus inhalers stolen from a distribution warehouse in 2009 have been found in some pharmacies. The safety and effectiveness of the stolen inhalers cannot be assured and they should not be used. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO) Advair Diskus (fluticasone propionate and salmeterol inhalation powder)...

2010-06-15 15:30:01

Armed with the right information, physicians can play a stronger role in ensuring asthma patients don't waver in taking drugs proven to prevent asthma attacks, according to researchers at Henry Ford Hospital in Detroit. The study finds patients are more likely to routinely take inhaled corticosteroids (ICS) for asthma control when physicians kept close watch over their medication use and reviewed detailed electronic prescription information, including how often patients fill their...

2010-06-02 18:17:00

WILMINGTON, Del., June 2 /PRNewswire-FirstCall/ -- Today, the U.S. Food and Drug Administration (FDA) released final label revisions for respiratory medications that contain an active ingredient known as a long-acting beta-agonist (LABA). This follows the FDA communication on 18 February 2010 requesting all manufacturers of LABA-containing medications to undertake class-labeling changes. (Logo: http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO ) The FDA made label revisions to...

2010-05-18 08:15:00

REDWOOD CITY, Calif., May 18 /PRNewswire/ -- Pearl Therapeutics Inc., a company developing clinically differentiated double and triple combination therapies for the treatment of highly prevalent chronic respiratory diseases, presented results from four studies that provide support for further development of PT003, the company's fixed dose combination of glycopyrrolate and formoterol delivered via a pressurized hydrofluoroalkane metered dose inhaler (HFA-MDI). The data were presented in a...

2010-05-17 08:00:00

REDWOOD CITY, Calif., May 17 /PRNewswire/ -- Pearl Therapeutics Inc., a company developing clinically differentiated double and triple combination therapies for the treatment of highly prevalent chronic respiratory diseases, has been named a TiE50 Winner in the BioSciences category, as a leader in innovation, ingenuity and management excellence. The award was presented to Pearl during TiEcon 2010, an annual convention hosted by The Indus Entrepreneurs (TiE), an organization dedicated to...

2010-05-05 07:00:00

REDWOOD CITY, Calif., May 5 /PRNewswire/ -- Pearl Therapeutics Inc., a company developing clinically differentiated double and triple combination therapies for the treatment of highly prevalent chronic respiratory diseases, today announced four upcoming poster presentations at the Annual Meeting of the American Thoracic Society (ATS) to be held at the Ernest N. Morial Convention Center in New Orleans from May 14-19, 2010. Results from Pearl's Phase 1 safety and pharmacokinetics study of...

2010-04-29 13:36:00

PHILADELPHIA, April 29 /PRNewswire/ -- In the United States alone, over 22 million people, including more than six million children, are known to have asthma, which is a leading cause of hospital emergency department visits and school absenteeism. In response to these alarming statistics, and in an effort to raise public awareness of the risks faced everyday by those living with asthma, Teva Respiratory is supporting National Asthma and Allergy Awareness Month as a Platinum sponsor of the...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.